跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GHRYVELIN 60 MG GRANULADO PARA SUSPENSIÓN ORAL EN SOBRE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GHRYVELIN 60 MG GRANULADO PARA SUSPENSIÓN ORAL EN SOBRE
Approved
STANDARD
GHRYVELIN 60 MG GRANULADO PARA SUSPENSIÓN ORAL EN SOBRE
Atnahs Pharma Netherlands Bv.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 28, 2021
Approval ID
545f5cd8da33aada
Company
Atnahs Pharma Netherlands Bv.
Type
Standard
Approval Details
Approval Id
545f5cd8da33aada
Drug Cima Aemps Name
GHRYVELIN 60 MG GRANULADO PARA SUSPENSIÓN ORAL EN SOBRE
Register Number
1181337001
Holder Company Name
Atnahs Pharma Netherlands Bv.
Marketing Company Name
Consilient Health Limited
Authorization Date
2021-12-28
Dosage Form
GRANULADO PARA SUSPENSIÓN ORAL
Dose
60 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Atnahs Pharma Netherlands Bv.
Active Ingredients
MACIMORELINA ACETATO
60 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 28, 2021
Approval ID
545f5cd8da33aada
Type
Standard
Back to CIMA-AEMPS Approvals